
Interested in economic evaluations of using patient reported outcome measures (PROMs) in cancer? Check out our paper on the eRAPID intervention in chemotherapy. Findings indicate potential cost benefit when online symptom monitoring is added to usual care ascopubs.org/doi/10.1200/OP.…














